Bellerophon Therapeutics, Inc.
Bellerophon Therapeutics, Inc. (BLPH) Stock Overview
Explore Bellerophon Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
146.8K
P/E Ratio
-0.01
EPS (TTM)
$-0.89
ROE
-1.64%
BLPH Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Bellerophon Therapeutics, Inc. (BLPH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.06.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.01 and a market capitalization of 146.8K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.